Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 188-195 , May 2006

Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients

  • Sabita S. Soedamah-Muthu

      Affiliations

    • Department of Epidemiology and Public-Health, Royal Free and University College London Medical School, London, UK
    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
    • Corresponding Author InformationCorresponding author. Julius Center for Health Sciences and Primary Care, University Medical Centre Utrecht, Huispostnr str. 6.131, PO Box 85500, Utrecht 3508 GA, The Netherlands. Tel.: +31 30 250 9379; fax: +31 30 250 5485.
    • ,
  • Nish Chaturvedi

      Affiliations

    • National Heart and Lung Institute, Imperial College London, London, UK
    • ,
  • Casper G. Schalkwijk

      Affiliations

    • Department of Clinical Chemistry, VU University Medical Centre, Amsterdam, the Netherlands
    • Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands
    • ,
  • Coen D.A. Stehouwer

      Affiliations

    • Department of Internal Medicine and the Institute for Cardiovascular Research, VU University Medical Centre, Amsterdam, the Netherlands
    • Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands
    • ,
  • Pertti Ebeling

      Affiliations

    • Department of Medicine, Helsinki University Hospital, Helsinki, Finland
    • ,
  • John H. Fuller

      Affiliations

    • Department of Epidemiology and Public-Health, Royal Free and University College London Medical School, London, UK
    • ,
  • The EURODIAB Prospective Complications Study group

Received 27 August 2004 ,Revised 13 May 2005 ,Accepted 20 June 2005.

References 

  1. Albertini JP, Valensi P, Lormeau B, et al. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care. 1998;21:1008–1013
  2. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie AK. Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study. Diabetologia. 1995;38:437–444
  3. Bannan S, Mansfield MW, Grant PJ. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia. 1998;41:460–466
  4. Chaturvedi N, Bandinelli S, Mangili R, et al. Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold. Kidney International. 2001;60:219–227
  5. Chaturvedi N, Fuller JH, Taskinen MR. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care. 2001;24:2071–2077
  6. Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CD. Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetes Care. 2002;25:2320–2327
  7. Clausen P, Jacobsen P, Rossing K, et al. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabetic Medicine. 2000;17:644–649
  8. Cominacini L, Fratta PA, Garbin U, et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control. Diabetologia. 1995;38:1122–1124
  9. Cominacini L, Fratta PA, Garbin U, et al. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress. Diabetologia. 1997;40:584–589
  10. de Lemos JA, Hennekens CH, Ridker PM. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. Journal of the American College of Cardiology. 2000;36:423–426
  11. Elhadd TA, Kennedy G, Hill A, et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes/Metabolism Research and Reviews. 1999;15:405–411
  12. EURODIAB IDDM Complications Study group . Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia. 1994;37:278–285
  13. Fasching P, Veitl M, Rohac M, et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism. 1996;81:4313–4317
  14. Fasching P, Waldhausl W, Wagner OF. Elevated circulating adhesion molecules in NIDDM—Potential mediators in diabetic macroangiopathy. Diabetologia. 1996;39:1242–1244
  15. Fossati P, Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry. 1982;28:2077–2080
  16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18:499–502
  17. Gearing AJ, Newman W. Circulating adhesion molecules in disease. Immunology Today. 1993;14:506–512
  18. Hirata K, Shikata K, Matsuda M, et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia. 1998;41:185–192
  19. Huo Y, Ley K. Adhesion molecules and atherogenesis. Acta Physiologica Scandinavica. 2001;173:35–43
  20. Jager A, van Hinsbergh VW, Kostense PJ, et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: The Hoorn Study. Diabetes. 2000;49:485–491
  21. Jager A, van Hinsbergh VW, Kostense PJ, et al. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology. 2002;22:593–598
  22. Jude EB, Douglas JT, Anderson SG, Young MJ, Boulton AJM. Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. European Journal of Internal Medicine. 2002;13:185–189
  23. Kearney EM, Mount JN, Watts GF, Slavin BM, Kind PR. Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. Journal of Clinical Pathology. 1987;40:465–468
  24. Knudsen ST, Foss CH, Poulsen PL, et al. E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy. American Journal of Physiology. Endocrinology and Metabolism. 2003;284:E1–E6
  25. Koga M, Otsuki M, Kubo M, Hashimoto J, Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabetic Medicine. 1998;15:661–667
  26. Koivisto VA, Stevens LK, Mattock M, et al. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care. 1996;19:689–697
  27. Malik I, Danesh J, Whincup P, et al. Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis. Lancet. 2001;358:971–975
  28. Matsumoto K, Sera Y, Ueki Y, et al. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabetic Medicine. 2002;19:822–826
  29. Mehta JL. Inflammatory and infectious basis of atherosclerosis. Basel, Switzerland: Birkhauser Verlag; 2001;[280 pp]
  30. Olson JA, Whitelaw CM, McHardy KC, Pearson DW, Forrester JV. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia. 1997;40:1166–1171
  31. Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes. 1997;46:2096–2101
  32. Pradhan AD, Rifai N, Ridker PM. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation. 2002;106:820–825
  33. Ribau JC, Hadcock SJ, Teoh K, DeReske M, Richardson M. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. The Journal of Surgical Research. 1999;85:225–233
  34. Richardson M, Hadcock SJ, DeReske M, Cybulsky MI. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arteriosclerosis and Thrombosis. 1994;14:760–769
  35. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 1993;362:801–809
  36. Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease. British Journal of Haematology. 1996;92:747–750
  37. Schram MT, Chaturvedi N, Schalkwijk C, et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: The EURODIAB prospective complications study. Diabetes Care. 2003;26:2165–2173
  38. Smulders RA, Stehouwer CD, Schalkwijk CG, et al. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus. Thrombosis and Haemostasis. 1998;80:52–57
  39. Stehouwer CD, Gall MA, Twisk JW, et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes. 2002;51:1157–1165
  40. Steiner M, Reinhardt KM, Krammer B, Ernst B, Blann AD. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thrombosis and Haemostasis. 1994;72:979–984
  41. Sugiuchi H, Uji Y, Okabe H, et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clinical Chemistry. 1995;41:717–723

PII: S1056-8727(05)00074-7

doi: 10.1016/j.jdiacomp.2005.06.005

Journal of Diabetes and Its Complications
Volume 20, Issue 3 , Pages 188-195 , May 2006

Article Tools